Gene Therapy, Oncolytic Viruses, Viral Vaccines CDMO Services
Our gene therapy viral vector process development and manufacturing capabilities are designed to confidently and rapidly progress your products from gene to market through development of robust and reproducible cGMP practices. Our technical teams have a deep understanding of viral vectors (AAV, Adenovirus, HSV, Lentivirus), oncolytic viruses, and viral vaccines.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
FUJIFILM Diosynth Biotechnologies
This website uses cookies to ensure you get the best experience on our website. Learn more